Page last updated: 2024-09-02

fingolimod hydrochloride and cysteine

fingolimod hydrochloride has been researched along with cysteine in 2 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (cysteine)	Trials (cysteine)	Recent Studies (post-2010) (cysteine)
2,771	157	2,062	40,132	418	11,457

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bromberg, JS; Fu, S; Gunn, MD; Honig, SM; Mao, X; Randolph, GJ; Yopp, A	1
Barbour, SE; Chalfant, CE; Griffiths, R; Milstien, S; Oskeritzian, CA; Payne, SG; Spiegel, S; Subramanian, P	1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and cysteine

Article	Year
FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. The Journal of clinical investigation, 2003, Volume: 111, Issue:5 Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemokine CCL19; Chemokines, CC; Chemotaxis, Leukocyte; Cysteine; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukotrienes; Lymph Nodes; Lysophospholipids; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Proteins; Phosphorylation; Propylene Glycols; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine; T-Lymphocytes	2003
The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. Blood, 2007, Feb-01, Volume: 109, Issue:3 Topics: Animals; Cell Degranulation; Cell Line; Cysteine; Cytosol; Eicosanoids; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukotrienes; Mast Cells; Phospholipases A; Phospholipases A2; Propylene Glycols; Prostaglandin D2; Rats; Receptors, Lysosphingolipid; Sphingosine	2007

Article

Year

FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.

The Journal of clinical investigation, 2003, Volume: 111, Issue:5

Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemokine CCL19; Chemokines, CC; Chemotaxis, Leukocyte; Cysteine; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukotrienes; Lymph Nodes; Lysophospholipids; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Proteins; Phosphorylation; Propylene Glycols; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine; T-Lymphocytes

2003

The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.

Blood, 2007, Feb-01, Volume: 109, Issue:3

Topics: Animals; Cell Degranulation; Cell Line; Cysteine; Cytosol; Eicosanoids; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Leukotrienes; Mast Cells; Phospholipases A; Phospholipases A2; Propylene Glycols; Prostaglandin D2; Rats; Receptors, Lysosphingolipid; Sphingosine

2007